Evidence map›Paper›PMID 37166763›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2023

Evaluating the effect of targeted strategies as control tools for hypervirulent meningococcal C outbreaks: a case study from Tuscany, Italy, 2015 to 2016.

Giorgio Guzzetta, Marco Ajelli, Alessandro Miglietta, Cecilia Fazio, Arianna Neri, Stefano Merler, Giovanni Rezza, Paola Stefanelli

Open access · diamondAbstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Giorgio GuzzettaCenter for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.
Marco AjelliCenter for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.
Alessandro MigliettaUnits of Epidemiology and Preventive Medicine, Central Tuscany Health Authority, Florence, Italy.
Cecilia FazioDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Arianna NeriDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Stefano MerlerCenter for Health Emergencies, Bruno Kessler Foundation, Trento, Italy.
Giovanni RezzaHealth Prevention Directorate, Ministry of Health, Rome, Italy.
Paola StefanelliDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Istituto Superiore di Sanità · ITFondazione Bruno Kessler · ITMinistero della Salute · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundMeningococcus (

Indexed as

Meningococcal InfectionsMeningococcal VaccinesNeisseria meningitidisNeisseria meningitidis, Serogroup CDisease OutbreaksHumansItalyMeningococcal Vaccinesagent-based modelcontact tracingoutbreak controlSerogroup C meningococcusvaccination

Identifiers

PMID37166763
PMCPMC10176827
OpenAlexW4376132391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.